A stent includes a strut formed into a cylindrical shape and extending in an axial direction. The strut includes outer peripheral portions extending around the axial and circumferential directions of the cylindrical shape. The outer peripheral portions are spaced apart from one another with gaps formed between adjacent outer peripheral portions. The strut includes a connection portion connecting the outer peripheral portions to each other in one of the gaps formed by the adjacent outer peripheral portions. The outer peripheral portions and the connection portion of the strut are integrally formed of a biodegradable polymer A portion of the strut includes a fragile portion which is snore fragile than other portions of the strut.

An extraluminal urethral prostate shield apparatus includes at least two collar members positionable around at least a portion of a bodily lumen. A plurality of longitudinal members securable between opposing faces of each of the at least two collar members in parallel array, surrounds the bodily lumen whereby obtrusion of enlarged tissue against the lumen is preventable and luminal patency is maintained.

The invention discloses a Zn—Ga series alloy and a preparation method and application thereof, belonging to the technical field of medical alloys. The Zn—Ga series alloy includes Zn and Ga, and Ga accounts for 0-30 wt % but not including 0. The preparation method is to mix Zn and Ga or Zn, Ga and trace elements, then to obtain a Zn—Ga series alloy by coating paint after smelting or sintering. The mechanical properties of the prepared Zn—Ga series alloy meet the requirements of the strength and toughness of medical implant materials, and it can be degraded in vivo. It has the dual characteristics of biological corrosion degradation and suitable corrosion rate to provide long-term effective mechanical support.

A stent comprising a hollow tubular body, for instance made of polymeric material, extending along and about a longitudinal axis between two opposite open axial ends and having a substantially cylindrical lateral wall delimiting a longitudinal inner conduit; the body comprising a plurality of deformable sections arranged in succession along the axis; each section comprises a plurality of longitudinal portions of the lateral wall and a plurality of radial cuts formed through the lateral wall and which separate the longitudinal portions from one another.

The present invention relates to a stent delivery device having: a first support rod into which a first movable body is inserted; a fixed magnet; and a second support rod into which a second movable body is inserted, wherein a first driving magnet included in the first movable body and a second driving magnet included in the second movable body rotate relative to each other by means of the control of an external magnetic field at a predetermined angle around an axis in a first direction with respect to the fixed magnet, thereby separating a first coupling piece and a second coupling piece from a first coupling groove and a second coupling groove and enabling a stent to unfold.

Provided is a ureteral stent for placement in a bladder, a kidney and a ureteral passageway connecting the bladder and the kidney. The ureteral stent includes a solid bladder portion free of a lumen positionable in the bladder, a tubular kidney portion positionable in the kidney and the ureteral passageway, and a tether connecting the bladder portion and the ureter portion to allow the bladder portion to float in the bladder and to allow a ureter orifice connecting the ureteral passageway to the bladder to move between a compressed state and an uncompressed state. By not having a lumen, the solid bladder portion allows the bladder to have a smaller diameter while maintaining a necessary uncoil force. The smaller diameter also allows the bladder portion to be inserted into a scope alongside a pusher tube, thereby avoiding loading the bladder portion onto a guidewire.

A stent includes a tubular body possessing a plurality of gaps. The tubular body includes a plurality of circumferentially extending linear struts. The stent includes a plurality of links connecting the linear struts. At least one of the links has first and second connection portions. The first connection portion is integrally formed with one strut, and the second connection portion is integrally formed with an adjacent strut. The stent includes a biodegradable material between the first connection portion and the second connection portion to connect the first and second connection portions to each other. The biodegradable material restrains the one strut and the adjacent strut from moving to their original shapes. The first and second connection portions move relative to one another in a separation direction when a connection by the biodegradable material is released so that the original shapes of the struts are restored.

An implantable device including a metal substrate; that contains particles having a size of 1 μm or more; if the wall thickness of the metal substrate is greater than or equal to 0.04 mm and less than or equal to 0.12 mm, the largest particle size is less than or equal to 15 μm and the average content of the particles is less than or equal to 40 ppm; if the wall thickness of the metal substrate is greater than 0.12 mm and less than or equal to 0.2 mm, the largest particle size is less than or equal to 20 μm and the average content of the particles is less than or equal to 100 ppm; The size of the particles and the average content of the particles are reasonably controlled according to the wall thickness of the metal substrate, improving the plastic deformation capability of the implantable device.

A kit of parts includes a urological device and a catheter. The urological device has a stem defining a lumen, a valve connected to a proximal portion of the stem and located in the lumen, and a head part connected to the stem and extending radially around the valve. The catheter is adapted to insert the urological device into a urethra of a user.

Aspects of the present invention relate to a method for locating an expandable implant for treating BPH within the prostatic urethra of a patient. The delivery device comprises an inner tube and an outer sleeve moveable relative to the inner tube between a stored position and a deployed position. The outer sleeve surrounds the inner tube to define an annulus therebetween and the expandable implant is retained within the annulus when the outer sleeve is in the stored position.